ITERUM THERAPEUTICS PLC's ticker is ITRM and the CUSIP is G6333L101. A total of 19 filers reported holding ITERUM THERAPEUTICS PLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,169,000 | +42.6% | 1,538,316 | 0.0% | 0.17% | +48.7% |
| Q4 2020 | $1,521,000 | -5.8% | 1,538,316 | 0.0% | 0.12% | -19.3% |
| Q3 2020 | $1,615,000 | -11.8% | 1,538,316 | 0.0% | 0.14% | -9.9% |
| Q2 2020 | $1,831,000 | -56.1% | 1,538,316 | 0.0% | 0.16% | -66.0% |
| Q1 2020 | $4,169,000 | -39.8% | 1,538,316 | 0.0% | 0.47% | -59.3% |
| Q4 2019 | $6,922,000 | -22.0% | 1,538,316 | 0.0% | 1.16% | -58.2% |
| Q3 2019 | $8,876,000 | -16.1% | 1,538,316 | 0.0% | 2.78% | +2.3% |
| Q2 2019 | $10,584,000 | -13.1% | 1,538,316 | 0.0% | 2.71% | -7.5% |
| Q1 2019 | $12,186,000 | +58.1% | 1,538,316 | 0.0% | 2.93% | +47.5% |
| Q4 2018 | $7,707,000 | -25.2% | 1,538,316 | 0.0% | 1.99% | +5.4% |
| Q3 2018 | $10,307,000 | -37.2% | 1,538,316 | 0.0% | 1.89% | -44.5% |
| Q2 2018 | $16,414,000 | – | 1,538,316 | – | 3.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 3,466,340 | $4,124,000 | 2.47% |
| New Leaf Venture Partners, L.L.C. | 1,456,303 | $1,733,000 | 0.50% |
| FRAZIER MANAGEMENT LLC | 1,538,316 | $1,831,000 | 0.16% |
| ARMISTICE CAPITAL, LLC | 1,262,553 | $1,502,000 | 0.07% |
| McAdam, LLC | 12,000 | $14,000 | 0.00% |
| UBS OCONNOR LLC | 88,009 | $105,000,000 | 0.00% |
| Cypress Capital Management LLC (WY) | 1,000 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 96 | $0 | 0.00% |
| Bollard Group LLC | 3,010 | $4,000 | 0.00% |